Emergency contraception - an evidence-based practice guide.
Emergency contraception ( EC) has the potential to reduce unintended pregnancy and abortion rates. This review provides an overview of the three main methods of EC available in Australia, including the copper intrauterine device and oral ECs, levonorgestrel and ulipristal acetate, and brings togethe...
| Publicado en: | Journal of Pharmacy Practice & Research Vol. 47; no. 6; pp. 486 - 494 |
|---|---|
| Autores principales: | , , |
| Formato: | algorithm review tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
Dec2017
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=126656531&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 126656531 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1445937X 6CKV jtl: Journal of Pharmacy Practice & Research issn: 1445937X maglogo: N pubinfo: dt: Dec2017 vid: 47 iid: 6 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 126656531 126656531 126656531 10.1002/jppr.1416 126656531 ppf: 486 ppct: 8 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Emergency contraception - an evidence-based practice guide. aug: au: Grzeskowiak, Luke E. Roberts, Claire T. Calabretto, Helen E. affil: Adelaide Medical School, Robinson Research Institute, University of Adelaide, Adelaide Australia sug: subj: Contraceptives, Postcoital Medical Practice, Evidence-Based Practice Guidelines Pregnancy, Unwanted Abortion, Induced Australia Intrauterine Devices Levonorgestrel Therapeutic Use Treatment Outcomes Evaluation Body Mass Index Drug Interactions Breast Feeding Decision Making Unsafe Sex Pharmacist Attitudes ab: Emergency contraception ( EC) has the potential to reduce unintended pregnancy and abortion rates. This review provides an overview of the three main methods of EC available in Australia, including the copper intrauterine device and oral ECs, levonorgestrel and ulipristal acetate, and brings together evidence from several guidelines to assist pharmacists' practices. The relative efficacy and safety of each method are discussed, together with practical recommendations regarding special considerations, including ongoing contraception, women with an elevated body mass index, drug interactions and breastfeeding. An evidence-based treatment algorithm is provided to assist in decision-making regarding EC use, with ulipristal acetate now likely to be the first-line oral EC given its superior efficacy relative to levonorgestrel, irrespective of time taken following unprotected sexual intercourse, but there are special considerations regarding its use. Pharmacists must be aware of key differences in available methods of EC and be prepared to counsel women on such to facilitate shared decision-making. pubtype: Academic Journal doctype: algorithm review tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|